Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'

Published Date: 31 Jul 2024

Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday.

Read Full News

Latest News

UK Commits $26.87 Million to Contain Ebola Outbreak in DRC

Britain has allocated up to 20 million pounds ($26.87 million) in ⁠new aid funding to help contain an Ebola outbreak in eastern ⁠Democratic Republic of the Congo, the UK's...

US Working With Small Biotech Firm on Experimental Ebola Treatment, HHS Official Says

U.S. officials are working with Mapp Biopharmaceutical to make an experimental Ebola treatment available for people who may have been exposed to ⁠the virus, an HHS official...

Congenital CMV Linked to Substantial Long-Term Health Issues

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV infection.

Why the Test-Negative Design Is Our Most Vital Tool for Vaccine Effectiveness

Dr Daskalakis explains vaccine study designs and how the science of test negative design, a decades-old, tried and true design, is now being called into question.

Test Shortages Slow Fight Against Ebola in Congo, WHO Official Says

Six tons of medical supplies to fight Ebola are set to arrive in the Democratic Republic of Congo on Tuesday, ⁠but limited testing capacity was slowing the response to the...

Bird Flu Found in Polar Bear in Europe for First Time

Bird flu has been detected in a dead polar bear in the ⁠Arctic Svalbard archipelago, the first time the virus has been found in the species in ⁠Europe.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Britain has allocated up to 20 million pounds ($26.87 million) in ⁠new aid funding to help contain an Ebola outbreak in eastern ⁠Democratic Republic of the Congo, the UK's...

U.S. officials are working with Mapp Biopharmaceutical to make an experimental Ebola treatment available for people who may have been exposed to ⁠the virus, an HHS official...

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV infection.

Dr Daskalakis explains vaccine study designs and how the science of test negative design, a decades-old, tried and true design, is now being called into question.

Six tons of medical supplies to fight Ebola are set to arrive in the Democratic Republic of Congo on Tuesday, ⁠but limited testing capacity was slowing the response to the...

Bird flu has been detected in a dead polar bear in the ⁠Arctic Svalbard archipelago, the first time the virus has been found in the species in ⁠Europe.

News All Time

Biomarkers Spot Invasive Aspergillosis Post-Lung Transplant

RNA testing may help assess the consequences of common environmental mold.

South Africa: Brit With Hantavirus Gradually Improving

The condition of a British man who was admitted ⁠to a hospital in Johannesburg after falling ill with hantavirus aboard ⁠a luxury cruise ship is gradually improving.

Pregnancy vs Postpartum Flare Rates Differ in RA and SpA

Patients with rheumatoid arthritis are more likely to experience flares during the early postpartum period than during pregnancy; however, flare rates in those with spondyloarthritis remain stable.

WHO Says Seven Cases Of Hantavirus Confirmed From Cruise Ship

Seven cases of the ⁠Andes hantavirus have now been confirmed among people ⁠who were passengers on board the ⁠cruise ship, the ‌World Health Organization said on...

A Child's First Flu May Set the Tone for Immunity

New research shows that a child's earliest encounter with the virus can 'imprint' the immune system, shaping how their antibodies respond to future infections.

First Lyme Vaccine in Decades Nears Approval

Positive phase 3 findings may reshape Lyme disease prevention among people with frequent tick exposure across endemic regions.

Prior Maternal Syphilis Boosts Congenital Infection Risk

A history of adequately treated syphilis before pregnancy is associated with more than a 100-fold increase in congenital syphilis risk.

Telemedicine in Pediatric Care Tied to Lower Antibiotic Use

Primary care telemedicine visits for acute respiratory tract infections in children are associated with a lower rate of antibiotic prescriptions than in-person visits.

US CDC Classifies Hantavirus Outbreak as 'level 3' Emergency Response, ABC News Reports

The ⁠U.S. Centers ⁠for Disease ⁠Control and ‌Prevention has classified the hantavirus ‌outbreak as 'level 3' ‌emergency ‌response, the ⁠lowest ‌level ⁠of emergency...

Does Mycoplasma genitalium Cause Recurrent Preterm Birth?

Mycoplasma genitalium infection shows an association with prior spontaneous preterm birth but does not increase the risk for recurrent spontaneous preterm birth.

Moderna's MRNA Flu Vaccine Outperforms Standard Shot in Late-stage Trial

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged ⁠50 and older,...

CDC Says It Is Monitoring US Travelers on Cruise Ship After Hantavirus Outbreak

The United States is closely monitoring the situation with U.S. travelers on board the luxury cruise ship that was ⁠hit by a hantavirus outbreak, the Centers for Disease...

US FDA Blocked Publication of COVID, Shingles Vaccine Safety Studies

Officials at the U.S. Food and Drug Administration blocked the publication of several studies supporting the ⁠safety of widely used vaccines against COVID-19 and shingles, a...

New Surveillance Study Supports Maternal RSV Vaccine Safety

Early data keep hypertension concerns on the radar, but more robust research shows no increased risk.

California's Highest Court Leans Toward Gilead in Considering Drugmakers' 'duty to Innovate'

California's highest court on Wednesday appeared skeptical of requiring Gilead Sciences and other manufacturers of drugs that are considered safe to try developing drugs...

Young Age, Lower BMI May Predict HIV Treatment Failure

Younger age, lower BMI for age, and lower CD4% at antiretroviral therapy initiation may predict treatment failure in children living with HIV.

Recommended News For You

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

Radioligand Therapy Set to Transform Oncology Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Women are more susceptible to the stress caused by inflation.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

Women who miss their first mammogram face higher risk of breast cancer death, study finds

Recommended Articles For You

Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma 

Phosphate Vs. Phosphorus: What Is The Difference? 

What Is A Normal Fibrinogen Level, And How Can It Affect Your Health 

Understanding Colon Cancer: Symptoms, Causes, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Relationship-building key to addressing oncologist shortages in rural care

1.

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook

2.

Colon cancer: Risk factors, warning signs and treatment options 

3.

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment

4.

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?

5.

The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

3.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot